Larvol Delta - Testing-the-Addition-of-an-AntiCancer-Drug-Daraxonrasib-for-Relapsed-or-Refractory-Solid-Tumors-With-RAS-Mutations

Rasonque (daraxonrasib) - Revolution Medicines

http://clinicaltrials.gov/ct2/show/NCT07819838

Sep 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next